Print Page

其 他 安 全 警 示

 
The United Kingdom: Class 4 Medicines Defect Information: Glaxosmithkline Consumer Healthcare (UK) Trading Limited, various products (English only)
 
Medicines and Healthcare products Regulatory Agency (MHRA) announces that Glaxosmithkline Consumer Healthcare (UK) Trading Limited (GSK) has informed MHRA that due to a machinery defect with the printing line, a small number of packs from the affected batches of the following products may not have the batch number and expiry date printed on the outer cartons. The correct information is printed on the blister pack and there is no concern with the product quality. These packs are not being recalled and this notice is for information. The affected products are:
- Beechams All In One Tablets (Active Pharmaceutical Ingredients: paracetamol, guaifenesin, phenylephrine hydrochloride)
- Piriteze Allergy Tablets (Active Pharmaceutical Ingredient: cetirizine)
- Piriton Allergy Tablets (Active Pharmaceutical Ingredient: chlorphenamine)
- Day Nurse Capsules (Active Pharmaceutical Ingredients: paracetamol, pseudoephedrine hydrochloride, pholcodine)
- Night Nurse Capsules (Active Pharmaceutical Ingredients: paracetamol, dextromethorphan hydrobromide, promethazine hydrochloride)
For details of the affected batches of the products, please refer to the website in MHRA.

Healthcare professionals, retailers and wholesalers are advised that if it is noticed that the pack(s) have missing information on the batch number and expiry date on the outer carton, do not supply and return to the company.

Please refer to the following website in MHRA for details: http://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-glaxosmithkline-consumer-healthcare-uk-trading-limited-various-products-el-20-a-22

In Hong Kong, the above products are not registered pharmaceutical products.

Ends/Tuesday, Apr 21, 2020
Issued at HKT 15:00
 
 
back